Drug Profile
Citric acid/lactic acid/potassium bitartrate - Evofem Biosciences/Rush University
Alternative Names: Acidform; Amphora; Amphora contraceptive vaginal gel; EVO 100; EVO-200; Femidence; Multipurpose Vaginal pH Regulator™; MVP-R; Phexxi; Phexxi®; PHEXXI™ vaginal gel 0.4%; PHEXXI™ vaginal gel 1%; PHEXXI™ vaginal gel 1.8%; VPRTMLatest Information Update: 14 Dec 2023
Price :
$50
*
At a glance
- Originator Rush University
- Developer Evofem Biosciences
- Class Anti-infectives; Antibacterials; Contraceptives; Electrolytes; Esters; Hydroxy acids; Lactates; Potassium compounds; Tricarboxylic acids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Pregnancy
- Preregistration Sexually transmitted infections
- Phase III Chlamydial infections; Gonorrhoea
- No development reported Bacterial vaginosis